Some articles have not been moved to our new site yet.
As a result you have been redirected to our old site.
If you wish to return to our new site - click here.
in the progress of clinical trials of cannabinoids.
have harvested 20,000 cannabis plants which are legally
grown under Home Office licenses at a 'secret location'
in the south of England. See photo
of the harvest. They are developing cannabis-based
medicine extracts which are based on an extract of whole
aim is to develop non-smoked medicines which are inhaled
by patients using a vaporizer which, when activated, releases
a metered dose of medicine. The device will allow patients
to benefit from the rapid relief from inhalation whilst
avoiding the inhalation of carcinogens in cannabis smoke.
GW are currently
in negotiation with the Canadian Ministry of Health to
provide cannabinoid preparations for clinical trials.
The Royal Pharmaceutical
Society are to undertake two clinical trials of cannabinoids,
involving placebo, synthetic THC and natural extracts,
using strict research protocols in order to secure World
Health Organisation approval should the trials produce
positive results. Dr Anita Holdcroft will be conducting
trials on pain relief in cancer patients and following
surgery. Dr John Zajicek will be coordinating trials of
efficacy for muscle spasms in around 100 MS patients,
with the support of the MS Society.
also proposes its own trials in around 2000 MS patients.
GW is part
of the UK Medicinal Cannabis Project which has just launched
a website where patients wishing to register their interest
in taking part in one of GW's clinical trials can complete
a patient questionnaire online (the questionnaire is located
in the "Patients" section of their website.)
. All information given is held medically in confidence
and will only be disclosed with your express permission.
Alternatively you can complete a paper version of the
questionnaire and the website gives details of how to
have a copy posted to you.
Whilst GW hope
to include as many patients as possible in their trials
they are unable to guarantee at this time that any individual
patient will be included in their programme. In the event
that you are selected for a trial your participation must
be supported by your doctor's consent and referral. GW
will therefore need to contact your doctor which is why
the questionnaire asks for both your permission to contact
your doctor and for your doctor's contact details.
If you are
a doctor and would like to tell GW about your experiences
with patients and the medicinal use of cannabis or are
interested in becoming involved in running a clinical
trial please complete the online Physician Questionnaire
located in the "Physician" section of the UK
Medicinal Cannabis Project's website.
Effie Road, London
(0171) 610 7171
(0171) 736 9861
Pharmaceutical Society of Great Britain
Lambeth High Street,